Published on by Global Academic Awards

Dr. Wei Shi | Probes | Best Researcher Award

Dr. Wei Shi | West China Second University Hospital of Sichuan University | China

Dr. Wei Shi is a medicinal chemist specializing in bioorthogonal chemistry, molecular imaging drugs, and targeted drug delivery, with a strong focus on applications in disease diagnosis and precision medicine. She earned her PhD from the West China School of Medical, Sichuan University, under Professor Wu Haoxing, her Master’s in medicinal chemistry from the West China School of Pharmacy under Professor He Ling, and her Bachelor’s in pharmaceutical engineering from Chongqing University of Technology. Currently working at the National Drug Clinical Trial Institution of West China Second Hospital, she manages clinical trial projects, alongside pharmacy and sample management. Dr. Shi has published impactful research in leading journals such as Angewandte Chemie International Edition, Organic Letters, and Journal of Organic Chemistry. Proficient in advanced analytical and synthesis techniques, she has received multiple academic scholarships and continues to advance innovative drug design and molecular imaging technologies

Publication Profile

Scopus

Orcid

Educational Background

Dr. Wei Shi holds a distinguished academic foundation in pharmaceutical sciences and medicinal chemistry, marked by progressive expertise in bioorthogonal chemistry and molecular imaging drugs. She earned her Doctorate from the West China School of Medical, West China Hospital, Sichuan University, under the mentorship of Professor Wu Haoxing, where her research focused on advanced medicinal chemistry applications for precision diagnostics and therapeutics. Prior to this, she completed her Master’s degree at the West China School of Pharmacy, Sichuan University, guided by Professor He Ling, concentrating on novel catalytic reactions and their applications in innovative drug design. Dr. Shi began her academic journey with a Bachelor’s degree in Pharmaceutical Engineering from Chongqing University of Technology, where she developed a strong technical foundation in pharmaceutical processes. This comprehensive educational background has equipped her with the skills, knowledge, and research acumen to contribute significantly to cutting-edge developments in drug synthesis, targeted delivery, and molecular imaging technologies.

Work and Research Experience

Dr. Wei Shi possesses extensive experience in medicinal chemistry research and clinical trial management. She has been working at the National Drug Clinical Trial Institution of West China Second Hospital, Sichuan University, where she oversees bioequivalence clinical trial project management, pharmacy supervision, sample handling, and blood analysis. During her doctoral studies at the West China School of Medical, she led projects on the scalable synthesis of unsymmetrical tetrazines, synergistic tumor photodynamic and chemotherapy based on tetrazine bioorthogonal reactions, and the development of tetrazine-based bioorthogonal fluorescence probes, managing all aspects from design to advanced analytical testing. Her master’s research at the West China School of Pharmacy focused on synthesizing benzodiazepine and 3-indolanone derivatives, optimizing reaction methods, and studying pharmacological activities. She also contributed to national natural science fund projects on fluorescent probe design, bioorthogonal reactions, and prodrug activation systems for live cell applications.

Honors and Awards

Dr. Wei Shi has been consistently recognized for her academic excellence and research achievements throughout her educational journey. She was honored with the prestigious National Scholarship in recognition of her outstanding scholarly contributions. During her doctoral studies at Sichuan University, she was awarded the Second-Class Scholarship for multiple consecutive years, reflecting her sustained commitment to high-level research and academic performance. Earlier, during her postgraduate studies, she earned the Third-Class Scholarship, highlighting her strong foundational research capabilities. In her self-assessment, Dr. Shi emphasizes her expertise in targeted drug delivery, molecular imaging drug design, bioorthogonal chemistry, drug synthesis and analysis, and their applications in disease diagnosis and precision medicine. She possesses the ability to independently conduct literature reviews, design experiments, synthesize and analyze compounds, and prepare scientific publications in English. Her combination of technical proficiency, innovative thinking, and dedication to advancing medicinal chemistry positions her as a capable and impactful contributor to her field.

Research Focus

Dr. Wei Shi’s research focus lies primarily within the fields of medicinal chemistry, bioorthogonal chemistry, and molecular imaging, with a strong emphasis on innovative chemical synthesis for biomedical applications. Her work on the organocatalytic and scalable synthesis of unsymmetrical 1,2,4,5-tetrazines by thiol-containing promotors represents a significant contribution to the development of chemical tools that can be applied in targeted drug delivery, diagnostic imaging, and precision medicine. This research bridges synthetic organic chemistry with chemical biology, enabling the creation of functional molecules that can be used for tumor imaging, photodynamic therapy, and controlled drug activation in biological systems. By integrating catalytic reaction design with scalable synthesis, Dr. Shi advances methodologies that are both efficient and practical for laboratory and potential clinical use. Her expertise extends to designing bioorthogonal probes, fluorescence imaging agents, and novel therapeutic strategies, positioning her research at the intersection of chemical innovation and medical application.

Publication Top Notes

Organocatalytic and Scalable Syntheses of Unsymmetrical 1,2,4,5-Tetrazines by Thiol-Containing Promotors

Year: 2019 | Citations: 54

Tuning the Physicochemical Properties of BODIPY for Bioimaging via meso-Amino Acylation

Year: 2022

One-Pot Synthesis of Seven-Membered Heterocyclic Derivatives of Diazepines Involving Copper-Catalyzed Rearrangement Cascade Allyl-Amination

Year: 2020 | Citations: 11

Regionally Selective Synthesis of Novel 3-Indolanones Catalyzed by Cuprous Iodide

Year: 2018

Conclusion

Dr. Wei Shi’s academic achievements, technical expertise, impactful publications, and commitment to innovative medicinal chemistry research position her as a strong contender for the Research for Best Researcher Award. Her focus on bioorthogonal chemistry and molecular imaging drugs aligns well with cutting-edge trends in precision medicine. With further expansion into international leadership roles and broader interdisciplinary research, she could become an even more prominent figure in her field. Based on her current trajectory and accomplishments, she is highly suitable for this award.

 

 

Wei Shi | Probes | Best Researcher Award

You May Also Like